Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON36459
NL-OMON36459
Not yet recruiting
Not Applicable

The use of the electronic nose in the diagnosis of patients with rheumatoid arthritis or psoriatic arthritis - e-nose RA and psoriatic arhtritis

Academisch Medisch Centrum0 sites45 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionspsoriatic arthritisrheumatiod arthritis1000381610023213

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
psoriatic arthritis
Sponsor
Academisch Medisch Centrum
Enrollment
45
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •RA patients 18\-75 years with:
  • •RA according to the ACR criteria
  • •DAS28 \* 3\.2
  • •No medication, or methotrexaat / hydroxychloroquine / sulfasalazine / leflunomide and/or prednison stable use \* 28 days;Psoriatic arthritis patients 18\-75 years with:
  • •PsA according to the CASPAR criteria
  • •DAS28 \* 3\.2
  • •No medication, or methotrexaat / sulfasalazine / leflunomide/ prednison stable use \* 28 days;Controls
  • •Non\-smoking (\< 5 pack\-years, \> 12 months)
  • •Rheumatoid factor IgM and anti\-CCP negative.

Exclusion Criteria

  • •RA and PsA patients
  • •Severe cardiovascular disease, history or present (Myocardial infarction, Coronary bypass surgery
  • •CVA, Pulmonary embolism and deep venous thrombosis, Heart failure)
  • •A history of diabetes mellitus
  • •Systemic inflammatory disease other than RA or PsA
  • •Active pulmonary disease, including extraarticular manifestation of RA, asthma, COPD, TBC, infection
  • •Cancer diagnosed and treated within 5 years, or known incomplete remission if earlier
  • •Presence or recent history (4 weeks) of paradontitis
  • •History of upper or lower respiratory infection in the past 4 weeks
  • •The use of inhalation medication in the past 4 weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Diagnostic Accuracy of an Electronic Nose as Compared to Combined Conventional CT-Scanning, Autofluorescense Scopy for the Detection of Early Endobronchial Squamous Cell Cancer after prior History of Head-and-neck Cancer or Lung CancerEarly Endobronchial Squamous Cell Cancer1002747610029107
NL-OMON36533Academisch Medisch Centrum315
Completed
Not Applicable
The electronic nose as a diagnostic tool in the discrimination of COPD and controls
NL-OMON23287Academic Medical Center Amsterdam, The Netherlands120
Completed
Not Applicable
An electronic nose in the screening for COPD in an at risk population of (ex-)smokers.COPD, smoking
NL-OMON20180Academic Medical CenterUniversity of AmsterdamDept. Pulmonology, F5-260Meibergdreef 91105 AZ AmsterdamThe NetherlandsUniversity Medical Center UtrechtUniversity of UtrechtDept. PulmonologyHeidelberglaan 1003584 CX UtrechtThe NetherlandsThe Nelson Study Group (Nederlands-Leuvens Longkanker Screeningsonderzoek).250
Recruiting
Not Applicable
Clinical study of a novel T-cell function assay for graft-versus-host disease (GVHD) after allogenic hematopoietic stem cell transplantatio
JPRN-UMIN000046860The University of Tokyo50
Completed
Not Applicable
Validation of a modified electronic nose for detection of oxidative stress in exhaled breathOXIDATIVERSTRESS
DRKS00015258Klinik für Anaesthesiologie, Klinikum der Universität München - Campus Großhadern15